These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21624820)

  • 21. Autoantibodies to thyroglobulin in health and disease.
    Rose NR; Burek CL
    Appl Biochem Biotechnol; 2000; 83(1-3):245-51; discussion 251-4, 297-313. PubMed ID: 10826964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis.
    Polosukhina DI; Kanyshkova TG; Doronin BM; Tyshkevich OB; Buneva VN; Boiko AN; Gusev EI; Favorova OO; Nevinsky GA
    J Cell Mol Med; 2004; 8(3):359-68. PubMed ID: 15491511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of autoantigens in the driving of autoimmune diseases.
    Roitt IM
    Immunol Ser; 1993; 59():119-29. PubMed ID: 7681695
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple Sclerosis: Enzymatic Cross Site-Specific Hydrolysis of H1 Histone by IgGs against H1, H2A, H2B, H3, H4 Histones, and Myelin Basic Protein.
    Nevinsky GA; Baranova SV; Buneva VN; Dmitrenok PS
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies in HIV-infected patients: Cross site-specific hydrolysis of H1 histone and myelin basic protein.
    Baranova SV; Dmitrienok PS; Buneva VN; Nevinsky GA
    Biofactors; 2019 Mar; 45(2):211-222. PubMed ID: 30496641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerosis and autoimmunity: a growing relationship.
    Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
    Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between EAE development in mice and the production of autoantibodies and abzymes after immunization of mice with different antigens.
    Aulova KS; Urusov AA; Sedykh SE; Toporkova LB; Lopatnikova JA; Buneva VN; Sennikov SV; Budde T; Meuth SG; Popova NA; Orlovskaya IA; Nevinsky GA
    J Cell Mol Med; 2021 Mar; 25(5):2493-2504. PubMed ID: 33560578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-CD69 autoantibodies cross-react with low density lipoprotein receptor-related protein 2 in systemic autoimmune diseases.
    Yu X; Matsui T; Otsuka M; Sekine T; Yamamoto K; Nishioka K; Kato T
    J Immunol; 2001 Jan; 166(2):1360-9. PubMed ID: 11145721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response.
    Routsias JG; Tzioufas AG
    J Autoimmun; 2010 Nov; 35(3):256-64. PubMed ID: 20643529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Introduction to medical abzymology: the present and the prospect].
    Suchkov SV; Gabibov AG
    Vestn Ross Akad Med Nauk; 2005; (10):44-53. PubMed ID: 16320706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity.
    Stathopoulos P; Chastre A; Waters P; Irani S; Fichtner ML; Benotti ES; Guthridge JM; Seifert J; Nowak RJ; Buckner JH; Holers VM; James JA; Hafler DA; O'Connor KC
    J Immunol; 2019 Apr; 202(8):2210-2219. PubMed ID: 30824481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease.
    Sim KY; Im KC; Park SG
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner.
    Albert H; Collin M; Dudziak D; Ravetch JV; Nimmerjahn F
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15005-9. PubMed ID: 18815375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody proteases: induction of catalytic response.
    Gabibov AG; Friboulet A; Thomas D; Demin AV; Ponomarenko NA; Vorobiev II; Pillet D; Paon M; Alexandrova ES; Telegin GB; Reshetnyak AV; Grigorieva OV; Gnuchev NV; Malishkin KA; Genkin DD
    Biochemistry (Mosc); 2002 Oct; 67(10):1168-79. PubMed ID: 12460115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural human antibodies to synthetic peptide autoantigens: correlations with age and autoimmune disease.
    Marchalonis JJ; Schluter SF; Wilson L; Yocum DE; Boyer JT; Kay MM
    Gerontology; 1993; 39(2):65-79. PubMed ID: 8514202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiribonuclease H2 antibodies are an immune biomarker for systemic lupus erythematosus.
    Nozawa K; Doe K; Uomori K; Sekigawa I; Takasaki Y; Yamaji K; Tamura N
    Autoimmunity; 2017 Jun; 50(4):241-246. PubMed ID: 28553742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera.
    Ricchiuti V; Briand JP; Meyer O; Isenberg DA; Pruijn G; Muller S
    Clin Exp Immunol; 1994 Mar; 95(3):397-407. PubMed ID: 7511075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of autoantibody glycosylation in autoimmune diseases.
    Goulabchand R; Vincent T; Batteux F; Eliaou JF; Guilpain P
    Autoimmun Rev; 2014 Jul; 13(7):742-50. PubMed ID: 24657512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.